All research
Oxytocin 2026-06-16 PubMed

Maternal L-thyroxine prevents PBDE-induced autistic-like social deficits and oxytocin depletion in mouse offspring.

Maternal Thyroid Supplementation Prevents Autistic-relevant Social Behavior and Hypothalamic Oxytocin Depletion Produced by Developmental Exposure to Environmental Toxicants.

Background

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with increasing prevalence, suspected to involve environmental factors. Polybrominated diphenyl ethers (PBDEs), common flame retardants, are known endocrine disruptors targeting the thyroid system. The thyroid system is crucial for brain development and regulates prosocial neuropeptides like oxytocin (OXT) and vasopressin (AVP). The specific link between PBDE-induced thyroid hormone deregulation, central OXT signaling disruption, and ASD-like social deficits has been unclear, representing a critical gap in understanding environmental neurotoxicity and potential interventions.

Study Design

Researchers used C57BL6/N mice to investigate developmental PBDE exposure. Dams received daily oral doses of corn oil vehicle, 0.1 mg/kg DE-71, or 0.4 mg/kg DE-71 during gestation and lactation, with or without concurrent maternal L-thyroxine (+mT4) supplementation. Offspring were then assessed for ASD-relevant behavioral responses and central neuroendocrine OXT neuron depletion. Gene expression of Mct8, Dio3, and Esr2 in paraventricular hypothalamic (PVH) OXT neurons was also analyzed to uncover underlying molecular mechanisms.

Results

Developmental exposure to the PBDE mixture DE-71 produced dose-dependent ASD-relevant behavioral responses and central neuroendocrine OXT neuron depletion in offspring. Molecular analysis revealed sex-specific changes in thyroid hormone-regulated pathways. In low-dose females, mRNA transcripts for the thyroid hormone transporter Mct8, deiodinase Dio3, and estrogen receptor beta Esr2 were significantly upregulated in PVH OXT neurons. Conversely, in low-dose males, Mct8 and Dio3 transcripts were downregulated. These findings highlight distinct molecular reprogramming events in hypothalamic neuroendocrine cells, leading to depleted central OXT signaling and ultimately ASD-relevant phenotypes.

Importantly, maternal L-thyroxine (+mT4) supplementation completely prevented both the ASD-relevant behavioral responses and the OXT neuron depletion caused by PBDE exposure.

Key Findings

  • Developmental PBDE exposure induced dose-dependent autistic-like social deficits in mouse offspring.
  • PBDE exposure led to central oxytocin neuron depletion in offspring.
  • Maternal L-thyroxine supplementation prevented both behavioral deficits and oxytocin depletion.
  • PBDEs caused sex-specific upregulation of Mct8, Dio3, Esr2 in female PVH OXT neurons.
  • PBDEs caused sex-specific downregulation of Mct8, Dio3 in male PVH OXT neurons.

Why It Matters

This study provides compelling evidence that maternal thyroid supplementation could be a therapeutic strategy against neurodevelopmental disorders induced by environmental toxicants like PBDEs. For individuals concerned about environmental exposures during pregnancy, optimizing maternal thyroid health, potentially through supplementation, might offer a protective mechanism. While this is a preclinical animal study, it points towards a critical, modifiable pathway. Future research needs to translate these findings into human clinical trials to establish safe and effective protocols for maternal thyroid support in at-risk populations, potentially influencing prenatal care guidelines.


maternal thyroid l-thyroxine pbde autism neurodevelopment oxytocin
Source: pubmed:42292908 · Ingested 2026-06-16 · Digest: gemini-2.5-flash